Statins and ARBs on Rheumatoid Activity
Recruiting now · Phase 3
Conditions studied: Rheumatoid Arthritis
In brief
Investigational and comparative study between the anti-inflammatory effectof both angiotensin reeptor blockers and statins on rheumatoid arthritis disease activity on Egyptian patients
Key facts
- Study ID
- NCT03770702
- Run by
- Sherief Abd-Elsalam
- People needed
- 45
- Starts
- 2018-10-01
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2018-12-10
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Rheumatoid arthritis.
You may not qualify if…
- Pregnant or lactating
- Hepatic or renal impairment.
Where it is running
- Sherief Abd-Elsalam — Tanta, Egypt (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.